When changing the route of administration the same dose must be used and the haemoglobin monitored every one or two weeks so that the appropriate dose adjustments can be made to keep the haemoglobin at the desired level.
(< 2 korda), kuid korduval manustamisel ootamatut kumulatsiooni ei toimunud.